The synthesis and evaluation of cyclic ureas as HIV protease inhibitors:: Modifications of the P1/P1′ residues

被引：29
|
作者：
Patel, M
Bacheler, LT
Rayner, MM
Cordova, BC
Klabe, RM
Erickson-Viitanen, S
Seitz, SP
机构：
[1] Dupont Merck Pharmaceut Co, Expt Stn, Dept Chem & Phys Sci, Wilmington, DE 19880 USA
[2] Dupont Merck Pharmaceut Co, Expt Stn, Dept Virol, Wilmington, DE 19880 USA
来源：
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 1998年 / 8卷 / 07期
关键词：
D O I：
10.1016/S0960-894X(98)00119-X
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
Two series of cyclic ureas modified at the P1/P1' residue were prepared and evaluated for HIV protease inhibition and whole cell antiviral activity. Compounds 8b, 10 (3- and 4-pyridylmethyl analogs) and 6b (4-methoxy analog) showed significant improvement in antiviral activity relative to lead compounds DMP323 and DMP 450. (C) 1998 The DuPont Merck Pharmaceutical Company. Published by Elsevier Science Ltd. All rights reserved.
引用
收藏
页码：823 / 828
页数：6
相关论文
共 50 条
  • [21] Novel spirocyclic pyrrolidones as P2/P1 mimetics in potent inhibitors of HIV-1 protease
    Kazmierski, WM
    Furfine, E
    Spaltenstein, A
    Wright, LL
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2002, 12 (23) : 3431 - 3433
  • [22] A new structural theme in C2-symmetric HIV-1 protease inhibitors:: ortho-Substituted P1/P1′ side chains
    Wannberg, Johan
    Sabnis, Yogesh A.
    Vrang, Lotta
    Samuelsson, Bertil
    Karlen, Anders
    Hallberg, Anders
    Larhed, Mats
    BIOORGANIC & MEDICINAL CHEMISTRY, 2006, 14 (15) : 5303 - 5315
  • [23] Gromov-Witten theory of P1 x P1 x P1
    Karp, Dagan
    Ranganathan, Dhruv
    JOURNAL OF PURE AND APPLIED ALGEBRA, 2016, 220 (08) : 3000 - 3009
  • [24] SYNTHESIS OF P1 BAN PROTEIN IN MINICELLS INFECTED BY P1 MUTANTS
    REEVE, JN
    LANKA, E
    SCHUSTER, H
    MOLECULAR AND GENERAL GENETICS, 1980, 177 (02): : 193 - 197
  • [25] On the Hilbert functions of sets of points in P1 x P1 x P1
    Guardo, Elena
    Van Tuyl, Adam
    MATHEMATICAL PROCEEDINGS OF THE CAMBRIDGE PHILOSOPHICAL SOCIETY, 2015, 159 (01) : 115 - 123
  • [26] HIV-1 PROTEASE INHIBITORS CONTAINING THE (HYDROXYETHYL) UREA ISOSTERE - MODIFICATION AT THE P1 POSITION
    FRESKOS, JN
    GETMAN, DP
    BRYANT, ML
    HOUSEMAN, KP
    MULLER, RA
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1993, 206 : 136 - MEDI
  • [27] Synthesis of novel, fluorinated P1 NS3 protease inhibitors of HCV
    Chen, Yan
    Sit, S. Y.
    Chen, Jie
    Sun, Li-Qiang
    D'Andrea, Stanley V.
    Zheng, Zhizhen
    Wang, Alan X.
    Hiebert, Sheldon
    Bowsher, Mike
    Cocuzza, Anthony
    Zhao, Qian
    Bilder, Donna
    Sin, Ny
    Venables, Brian L.
    Carini, David
    Johnson, Barry
    Mull, Eric
    Hernandez, Dennis
    Sheaffer, Amy K.
    Mulherin, Heather
    Yu, Fei
    Knipe, Jay O.
    Mosure, Kathy
    Good, Andrew C.
    Rajamani, Ramkumar
    Klei, Herbert
    Friborg, Jacques
    Arora, Vinod
    Shu, Yue-Zhong
    Huang, Xiaohua
    Levesque, L.
    Li, Danshi
    Zhu, J.
    Adam, S.
    McPhee, Fiona
    Meanwell, Nicholas
    Scola, Paul M.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2010, 240
  • [28] The stability manifolds of P1 and local P1
    Bertram, Aaron
    Marcus, Steffen
    Wang, Jie
    HODGE THEORY AND CLASSICAL ALGEBRAIC GEOMETRY, 2015, 647 : 1 - 17
  • [29] Synthesis and evaluation of potent human immunodeficiency virus 1 protease inhibitors with epimeric isopropanol as novel P1′ ligands
    Zhu, Mei
    Ma, Ling
    Dong, Biao
    Zhang, Guoning
    Wang, Juxian
    Zhou, Jinming
    Cen, Shan
    Wang, Yucheng
    FUTURE MEDICINAL CHEMISTRY, 2020, 12 (09) : 775 - 794
  • [30] Evaluation of P1′ substrate specificity of staphylococcal SpIB protease
    Pustelny, Katarzyna
    Stach, Natalia
    Wladyka, Benedykt
    Dubin, Adam
    Dubin, Grzegorz
    ACTA BIOCHIMICA POLONICA, 2014, 61 (01) : 149 - 152
12345